E
PharmaCielo Ltd. PCLO.V
TSX
Recommendation
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

09/30/2024 06/30/2024 03/31/2024 12/31/2023 09/30/2023
Revenue -8.31% -45.28% -80.15% -72.06% -35.91%
Total Other Revenue -- -- -- -- --
Total Revenue -8.31% -45.28% -80.15% -72.06% -35.91%
Cost of Revenue -31.06% -39.30% -41.23% -34.21% -10.98%
Gross Profit 102.78% 18.68% -346.24% -225.94% -492.55%
SG&A Expenses -40.38% -40.75% -41.79% -31.31% -25.24%
Depreciation & Amortization 149.75% 243.91% -12.28% -34.42% -130.77%
Other Operating Expenses 27.97% -45.51% -224.83% -- --
Total Operating Expenses -33.31% -37.78% -41.26% -32.64% -31.91%
Operating Income 40.49% 35.83% 24.11% 13.85% 30.67%
Income Before Tax -8.51% 8.59% 2.44% -7.95% 22.63%
Income Tax Expenses -- -- -- -- --
Earnings from Continuing Operations -8.51% 8.59% 2.44% -7.95% 22.63%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -8.51% 8.59% 2.44% -7.95% 22.63%
EBIT 40.49% 35.83% 24.11% 13.85% 30.67%
EBITDA 35.56% 34.77% 21.52% 13.17% 31.94%
EPS Basic -1.97% 15.61% 9.26% -1.35% 25.67%
Normalized Basic EPS 24.85% 33.41% 25.53% 15.40% 33.60%
EPS Diluted -1.97% 15.61% 9.26% -1.35% 25.67%
Normalized Diluted EPS 24.85% 33.41% 25.53% 15.40% 33.60%
Average Basic Shares Outstanding 6.51% 8.39% 7.37% 6.02% 4.38%
Average Diluted Shares Outstanding 6.51% 8.39% 7.37% 6.02% 4.38%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --
Weiss Ratings